Culprit vessel only versus multivessel percutaneous coronary intervention in patients presenting with ST-segment

Dongfeng Zhang1, Xiantao Song1, Shuzheng Lv1

  • 1Department of Cardiology, Capital Medical University affiliated Beijing Anzhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Disease, Beijing, China.

Plos One
|March 22, 2014
PubMed

Insights

For ST-elevation myocardial infarction (STEMI) with multivessel disease (MVD), treating only the culprit artery during percutaneous coronary intervention (PCI) is linked to better outcomes than multivessel PCI (MV-PCI). This approach reduces mortality and renal dysfunction risk.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Research

Background:

  • Optimal treatment strategy for ST-segment elevation myocardial infarction (STEMI) patients with multivessel disease (MVD) undergoing primary percutaneous coronary intervention (PCI) remains unclear.
  • Multivessel disease (MVD) is common in STEMI patients, necessitating careful consideration of intervention scope.

Purpose of the Study:

  • To compare the clinical outcomes of culprit vessel only percutaneous coronary intervention (culprit PCI) versus multivessel percutaneous coronary intervention (MV-PCI) in STEMI patients with MVD.
  • To provide evidence-based recommendations for PCI strategy in STEMI with MVD through a comprehensive meta-analysis.

Main Methods:

  • Systematic literature search of major databases (PubMed, Elsevier, Embase, CNKI) for relevant randomized and non-randomized studies.
  • Meta-analysis of included studies using Review Manager 5.1 to compare outcomes between culprit PCI and MV-PCI strategies.
  • Inclusion of data from 4 randomized and 14 non-randomized studies, encompassing 39,390 patients.

Main Results:

  • Multivessel PCI (MV-PCI) was associated with increased short-term and long-term mortality compared to culprit vessel only PCI (culprit PCI).
  • MV-PCI also showed a higher risk of renal dysfunction.
  • Conversely, MV-PCI demonstrated a reduced incidence of revascularization compared to culprit PCI.

Conclusions:

  • The findings support current guidelines recommending against treating non-culprit vessels during the index procedure for STEMI patients with MVD.
  • Culprit vessel only PCI appears to be a safer strategy regarding mortality and renal outcomes in this patient population.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522